TrialMedical oncology (Northwood, London, England)2016

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial.

Fabien Calcagno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.